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Abstract: Quadruplex DNA structures are attracting an enormous interest in many areas of 
chemistry, ranging from chemical biology, supramolecular chemistry to nanoscience. We 
have prepared carbohydrate–DNA conjugates containing the oligonucleotide sequences of G-
quadruplexes (thrombin binding aptamer (TBA) and human telomere (TEL)), measured their 
thermal stability and studied their structure in solution by using NMR and molecular 
dynamics. The solution structure of a fucose–TBA conjugate shows stacking interactions 
between the carbohydrate and the DNA G-tetrad in addition to hydrogen bonding and 
hydrophobic contacts. We have also shown that attaching carbohydrates at the 5’-end of a 
quadruplex telomeric sequence can alter its folding topology. These results suggest the 
possibility of modulating the folding of the G-quadruplex by linking carbohydrates and have 
clear implications in molecular recognition and the design of new G-quadruplex ligands. 
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Introduction 
 
G-quadruplexes consist of a square arrangement of guanines (G-tetrad), 
stabilized by Hoogsteen hydrogen-bonding and by monovalent cations (especially 
potassium) coordinated in the center, located between two G-tetrads. The in vivo 
evidence of the existence of G-quadruplexes at telomeres[1] and oncogene 
promoters,[2] as well as their role in controlling different biological processes,[3] 
have converted them in primary research targets for therapeutical applications.[4] 
Consequently, a variety of ligands has been designed and prepared to bind G-
quadruplexes as a new class of anticancer drugs. Some examples of quadruplex 
binders have been reported to bind through groove specific contacts of the 
quadruplex structure.[5] However, most quadruplex ligands described to date use 
aromatic pi-stacking as the main driving force for binding on the G-tetrad 
platform.[6]  
 
In addition, G-quadruplexes are a very attractive motif in the development 
of structural and functional supramolecular assemblies,[7] and in DNA-based 
nanodevices.[8] The possibility of modulating the physicochemical properties of a 
G-quadruplex by its conjugation to small molecules is also being explored, 
especially through attaching large aromatic groups.[9]  
 
We have used carbohydrate oligonucleotide conjugates (COCs) to study 
carbohydrate-DNA interactions in double helices adapting a dangling end DNA 
model system traditionally used to study pi–pi stacking interactions.[10] The sugar 
moiety is attached to the 5’-end of the DNA sequence in our COCs. In previous 
work, we observed that natural highly polar carbohydrates stack onto the terminal 
DNA base pair of a duplex through CH/pi interactions.[11] However, DNA stability is 
only increased when the sugars stack on C–G or G–C base pairs. If COCs contained 
permethylated carbohydrates, apolar versions of the natural sugars, a notable 
increase in double-stranded DNA stability was found in comparison with the natural 
polyhydroxylated mono- and disaccharide DNA conjugates. Moreover, these apolar 
carbohydrates are also capable of stabilizing duplexes with A–T or T–A terminal 
base-pairs.[12] We hypothesized that the CH–pi pseudo hydrogen-bonds in addition 
to the higher hydrophobicity imparted by the methyl groups are responsible for 
duplex stabilization.  
 
Due to the relevance of the G-quadruplex DNA and RNA structures we 
decided to explore the possible carbohydrate– DNA interactions in a G-quadruplex 
context. Herein we describe the preparation of COCs containing the oligonucleotide 
sequence of a G-quadruplex and sugars attached to the 5’-end. The idea was to 
examine the possibility of carbohydrate interactions on top of the nearby G-tetrad 
and investigate how these contacts could affect quadruplex stability and structure. 
We have prepared COCs containing the thrombin-binding aptamer (TBA) and the 
human telomere (TEL) sequences in which the carbohydrates were covalently linked 
through an ethylene glycol spacer (Figure 1). Saccharides conjugated to a G-
quadruplex-forming sequence (5’-TGGGAG) have been reported previously as anti-
HIV agents.[13] The TBA sequence (Figure 1A) was selected due to the detailed 
knowledge of its 3D structure[14] and because of the high number of chemically 
modified TBA sequences (containing reverse natural bases,[15] extra natural 
bases,[16] modified bases,[17] and unnatural nucleosides[18]) and TBA conjugates 
(linked to small molecules[19] and to nanostructures).[20] 
 
 
 
 
 
 
Figure 1. A) Sequence of the thrombin-binding aptamer (TBA). B) Schematic model of the 
carbohydrate–TBA conjugates. C) Enlarged top-view of monosaccharide–TBA conjugate. 
 
Results and Discussion 
 
The COCs were synthesized by using standard solid-phase 
oligonucleotide automatic synthesis. Mono- and disaccharides were 
covalently bound to the TBA sequence by using the corresponding 
carbohydrate phosphoramidite derivative (Figure 1 and Figure 2).[11, 21] 
β-D-glucose, β-D-galactose and β-D-fucose were selected monsaccarides, 
whereas β-D-maltose, β-D-lactse ans β-D-cellobiose were the chosen 
disaccharides. Also, two apolar sugars, permethylated glucose and maltose, 
were attached to the TBA sequence by using a similar synthetic strategy 
[12]. 
 
The thermal stability of the carbohydrate TBA conjugates was 
measured by UV-monitored thermal denaturation experiments in a pH 7.0 
cacodylate buffer containing KCl (100 mM) (Table 1). All COCs containing 
natural carbohydrates (4–9) showed a lower thermal stability than the 
natural TBA (1). The reduction in Tm values ranges from 5.7 to 6.8 ºC. 
However, it is important to note that the addition of a phosphate group at 
the 5’-end of the TBA quadruplex (compound 2) provokes a destabilization 
of 4.5 ºC with respect to unmodified TBA 1. Furthermore, when the spacer 
is attached to the TBA sequence (compound 3) the decrease of Tm in 
comparison with TBA is 7.5 ºC. Therefore, compound 3 must be considered 
the proper control to evaluate the carbohydrate contribution to the thermal 
stability of the different conjugates. Thus, ∆Tm values of the natural 
carbohydrate TBA conjugates (4–9) with respect to the spacer– TBA 
conjugate (3) indicate an increase in stability between 0.7 and 1.8 ºC (see 
right column on Table 1). Thermodynamic analysis of the UV melting-curves 
were obtained by curve-fitting as described in the literature.[22] Free 
energies confirmed the trend observed in the Tm values. Moreover, a 
greater enthalpic contribution to the stability of their folded structure is 
observed in all carbohydrate–TBA conjugates with respect to the spacer-
TBA conjugate (3) and to natural TBA (1), which could be attributed to the 
new molecular interactions between carbohydrates and the G-quadruplex. 
 
 
 
 
 
Figure 2. Carbohydrate–TBA conjugates and oligonucleotide controls prepared for this study. 
 
A similar scenario is observed when apolar carbohydrates are bound 
to the 5’-end of the TBA oligonucleotide. COCs containing permethylated 
glucose and maltose (10 and 11) also show a decrease in Tm values in 
comparison with TBA (4.7 and 10.1 ºC, respectively). Nevertheless, the TBA 
conjugate with the apolar version of glucose (10) is 2.8 ºC more stable than 
the control spacer- TBA (3) contributing to moderately improved TBA 
stability. The addition of the natural and sugars to the conjugate 3 is able to 
recover, to some extent, the TBA G-quadruplex stability. These results 
indicate that favorable carbohydrate– DNA interactions are taking place.  
 
We also measured the thermal stability of oligonucleotide TBA 
sequences with an extra base at the 5’-end (thymidine, sequence 12 and 
adenine, sequence 13). A decrease in Tm value was observed for both 
sequences (6.0 and 6.3 ºC, respectively) with respect to the unmodified 
TBA (1). Comparable results were obtained by Smirnov et al.;[23] these 
values are similar to those obtained for COCs with the natural 
carbohydrates and a similar behavior could be envisioned. It is important to 
note that here the “spacer” of the natural aromatic base is deoxyribose, 
which is conformationally more restricted than ethylene glycol, the spacer 
used for the mono- and disaccharide TBA conjugates.  
 
To confirm that the observed increased stability in COCs is due to 
carbohydrate–G-tetrad interaction, the structure of TBA–carbohydrate 
conjugates containing two mono- and three disaccharides (compounds 5, 6, 
7, 8, and 9) was studied by NMR spectroscopy, circular dichroism (CD), and 
gel electrophoresis. CD spectra clearly show that all conjugates adopt 
antiparallel G-quadruplex structures (see Figure S1 in the Supporting 
Information). Gel electrophoresis experiments conducted under non-
denaturating conditions show single bands for monosaccharide–TBA 
conjugates, running as the native TBA. However, two bands are observed 
for the disaccharide–TBA conjugates (Figure S2 in the Supporting 
Information). Since the melting temperatures of these conjugates do not 
depend on oligonucleotide concentration (Table S1 in the Supporting 
Information), we conclude that the two bands observed in the gels 
correspond to two monomeric species with different conformations. 
 
Table 1. Melting temperatures Tm values (ºC) for the carbohydrate–oligonucleotide 
conjugates containing the thrombin-binding aptamer sequence and the 
corresponding oligonucleotide controls.[a] 
 
5’-X-
GGTTGGTGTGGTTGG 
Tm          
(° 
C) 
∆ Tm         
[ºC][b] 
∆Tm* 
[ºC][c] 
−∆S°          
(cal/k · 
mol) 
−∆H° 
(kcal/mol)  
∆Go37 
(kcal/mol) 
∆∆G°37  
(kcal/mol)[d]   
∆∆G°37 * 
(kcal/mol)[e]   
(none)       1 48.2 
± 0.5 
- −7.5 117.5±2 37.7 -2.8 - -1.0 
PO3
—[f]
      2 43.7 
± 0.2 
−4.5 −3.0 134.1±2 42.3 -2.3 0.5 -0.5 
HO-C2-OPO
2
—[f]
      3 40.7 
± 0.2 
−7.5 - 119.8±1 37.5 -1.8 1.0 - 
β-D-glucose-C2-OPO
2
-—[f]
   
4 
42.5 
± 0.2 
−5.7 +1.8 132.3±1 41.7 -2.2 0.6 -0.4 
β-D-galactose-C2-OPO
2
—
[f] 5 
41.4 
± 0.2 
−6.8 +0.7 135.1±2 42.3 -2.0 0.8 -0.2 
β-L-fucose-C2-OPO
2
—[f] 
  6 42.3 
± 0.2 
−5.9 +1.6 135.7±2 42.6 -2.2 0.6 -0.4 
β-D-maltose-C2-OPO
2
-—[f] 
  
7 
41.7 
± 0.2 
−6.5 +1.0 133.7±2 42.0 -2.1 0.7 -0.3 
β-D-lactose-C2-OPO
2
-—[f] 
  8 41.5 
± 0.3 
−6.7 +0.8 139.7±2 43.8 -2.2 0.6 -0.4 
β-D-cellobiose-C2-OPO
2
-
-    
9 
41.8 
± 0.3 
−6.4 +1.1 136.9±2 42.9 -2.1 0.7 -0.3 
β-D-glucose(Me)-C2-OPO
2
—
[f] 
  10 
43.5 
± 0.7 
−4.7 +2.8 134.1±1 42.4 -2.4 0.4 -0.6 
β-D-maltose(Me)-C2- 38.1 
± 0.4 
−10.1 −1.6 127.2 
±2 
39.7 -1.8 1.0 0.0 
OPO
2
—[f] 
  11 
2’-deoxythymidine-OPO
2
-
-   
12  
42.2 
± 0.1 
−6.0 +1.5 141.5 
±3 
44.4 -2.2 0.6 -0.4 
2’-deoxyadenosine-OPO
2
-
-    
13 
41.9 
± 0.1 
−6.3 +1.2 139.2 
±2 
43.8 -2.3 0.5 -0.5 
[a] Buffer: 10 mM Na●cacodylate, 100mM KCl, pH 7.0; Tm values are the average of three experiments measured at 5 µM conc.; [b] ∆Tm = Tm (5’-
modified TBA sequence) – Tm (TBA control sequence); [c] ∆ Tm* = Tm (5’-modified TBA sequence) – Tm (5’-spacer-OPO2-- TBA sequence). [d] 
∆∆G°37  = ∆G (5’-modified TBA sequence) – ∆G (TBA control sequence); [e] ∆∆G°37 * = ∆G (5’-modified TBA sequence) – ∆G (5’-spacer-
OPO2- – TBA sequence). [f] C2 stands for –CH2-CH2-; 
The imino proton region of the NMR spectra clearly indicates that all 
conjugates adopt a quadruplex structure with two guanine tetrads (Figure 
S3 in the Supporting Information). Exchangeable proton signals could be 
assigned on the basis of the strong similarity between the spectra of the 
conjugates and the unmodified aptamer. Assignment of most non-
exchangeable protons could be carried out following standard bidimensional 
techniques, and were confirmed with previously reported assignment of 
native TBA (see Figures 3 and 4 and the Supporting Information for 
assignment tables).  
 
In the case of the disaccharide conjugates, spectral assignment was 
complicated due to the presence of additional spin-systems. After sequential 
assignment, we concluded that these systems correspond to two species, 
affecting protons in residues G6, T7, and G8 (see Figure 3), being both 
species in slow equilibrium on the NMR timescale. The chemical shifts of one 
of the conformations are almost coincident with those of the native 
aptamer.  
 
This effect is not observed in the monosaccharide–TBA conjugates, in 
which single species are observed. The different behavior between mono- 
and disaccharide conjugates is consistent with the non-denaturating gel 
experiments. Chemical shift differences between equivalent protons in 
modified- and unmodified TBA are shown in Figure S4 (the Supporting 
Information). Most protons in COCs exhibit very similar chemical shifts to 
the natural TBA except those in residue G1 and in the neighborhood of the 
TGT loop (mainly, protons in residues G6, T7, and G8). Interestingly, the 
profile of chemical shift differences is very similar in all the conjugates. 
 
 
 
  
Figure 3. Region of the NOESY spectra of the maltose–TBA conjugate (7) superimposed onto 
the native TBA (1, pink) spectra. Sequential assignment pathways show the two different 
species for residues G6, T7 and G8 (labeled in different colors). 
 
NOE data also indicate that all conjugates maintain a similar structure 
as the native TBA. Exchangeable NOE patterns are consistent with 
formation of two G-tetrads. The strong intensities of intraresidue NOE cross-
peaks between guanine H8 and H1’ protons confirmed the syn conformation 
for the glycosydic angle of G1, G5, G10, and G14. Stacking of the lateral 
loop thymines, T4 and T13, on top of the adjacent guanines, G2 and G11, is 
corroborated by several strong NOEs. However, some differences in NOE 
cross-peaks are observed in the TGT loop suggesting that the carbohydrate 
affects its structure and alters the interaction of residues G8 and T9 with 
the nearby tetrad (G1:G6:G10:G15; see Figure 4 and Table S2 in the 
Supporting Information). 
 
 
 
 
 
Figure 4. Regions of the NOESY experiments of fucose–TBA conjugate (6). Contour plots of 
the carbohydrate–DNA NOEs are shown in red. 
 
Most interestingly, several carbohydrate–DNA NOEs could be detected 
in all conjugates. The number of these NOEs is particularly high in the case 
of conjugate 6 (fucose–TBA), most probably due to the presence of a 
methyl group in this carbohydrate; this resonance is easily identified and 
does not overlap with other signals of the conjugate (see Figure 4, top).  
 
The solution structure of conjugate 6 was determined on the basis of 
experimental NOE constraints. Restrained molecular- dynamics calculations 
were carried out with the AMBER package as explained in the Methods 
section in the Supporting Information. A total of 142 distance constraints 
(10 between carbohydrate and DNA) were used in the calculation (Table S2, 
the Supporting Information). Structures were deposited in the Protein Data 
Bank (2lyg). As shown in Figure 5, the resulting structures are well-defined. 
The solution structure of the fucose–TBA conjugate resembles the general 
fold of the unmodified aptamer. The main differences are in the TGT loop-
region in which the fucose moiety displaces the nucleobases of residues G8 
and T9 and stacks on top of G1 and G15 (see Figure 5, bottom). In fact, 
fucose interaction with the guanine tetrad seems to occur by an induced-fit 
mechanism. In addition to the stacking interaction with the adjacent tetrad, 
fucose O5 is at a hydrogen bond distance of one amino proton of G8 (see 
Figure 6). Also, a favorable hydrophobic interaction occurs between fucose 
and T9 methyl groups (Figure 6). The T7 base tends to insert into the 
quadruplex groove. The carbohydrate maintains the usual 4C1 chair 
conformation.  
 
The structure of the conjugate 6 is totally consistent with the 
observed NOEs and the profiles of chemical shift differences between this 
conjugate and the native aptamer. Chemical shifts are very sensitive to 
structural variations. Therefore, the strong similarity between DNA proton 
resonances in the two monosaccharide–DNA conjugates implies that 
fucose–TBA and galactose–TBA adopt very similar conformations (see 
Figure S5 in the Supporting Information). Although in the latter the number 
of carbohydrate– DNA NOEs is lower, this is not due to a different 
conformation of the galactose in the conjugate, but to the lack of the fucose 
methyl-group that facilitates the detection of carbohydrate– DNA NOEs. 
 
 Inspection of the structure of fucose–TBA shows that the site 
occupied by the fucose sugar cannot be easily occupied by a disaccharide 
without further disruption of the TGT loop (see Figure 5). Most probably, 
this is the reason of the two species observed in the NMR spectra of the 
disaccharide conjugates, and confirmed by electrophoretic gels. 1H chemical 
shifts and NOEs suggest that in one species the disaccharide interacts with 
the G-tetrad disrupting the TGT loop, and in the other, the TGT loop adopts 
a native-like conformation with the disaccharide mainly disordered (Figure 
7). Presumably, this second species has a different electrophoretic mobility 
(see Figure S2 in the Supporting Information). At the same time, this 
equilibrium must be affecting the stability of the carbohydrate–TBA 
conjugate.  
 
It is worth mentioning that the disaccharide–TBA conjugates are not 
more stable than the monosaccharide–TBA conjugates, as observed in the 
case of sugar-capping DNA duplexes.[11–12] The stabilization conferred to 
the TBA by the different carbohydrates is more difficult to interpret than in 
the case of carbohydrates stacking at the terminal base of double helices. In 
the latter, the increase in thermal stability is a direct measurement of a 
favorable interaction of the carbohydrate with the terminal base pair. 
However, in TBA conjugates the carbohydrate G-tetrad interaction competes 
with native nucleobase pi-stacking interactions. This event is difficult to 
circumvent because G-tetrads are rarely exposed to the solvent. In fact, the 
capping interactions in the terminal G-tetrads affect dramatically the folding 
topology of the quadruplex. 
 
Interfering with capping interactions by conjugating carbohydrates 
makes it possible to modulate G-quadruplex folding, since the particular 
topology adopted by a G-rich oligonucleotide depends strongly on capping 
interactions between terminal G-tetrads and nucleotides in the loops. In 
many cases, terminal residues are also involved in these interactions, as 
observed in human telomeric sequences. As a proof of concept, we have 
explored the effect of substituting the 5’- terminal thymine of the 
oligonucleotide 5’-TAGGGTTAGGGT- 3’ (TEL) with a carbohydrate. TEL folds 
as a G-quadruplex containing two repeats of the human telomeric 
sequence, and its structure has been studied by NMR spectroscopy and X-
ray crystallography. In the crystallographic structure TEL forms a dimeric 
parallel propeller-like quadruplex.[24] However, in solution, TEL exists in an 
equilibrium between dimeric parallel and antiparallel structures, being the 
latter predominant in Na+ buffer.[25]  
 
As it can be observed in Figure 8, the NMR spectra of TEL and β-D-
glucose-C2-OPO2-AGGGTTAGGGT 14 are dramatically different. As 
previously reported, the TEL spectra exhibit many broad imino signals, 
indicating the presence of multiple conformations. A similar complexity is 
observed in the control spacer-OPO2-AGGGTTAGGGT conjugate 15 (see 
Figure S9 in the Supporting Information). 
 
 
 
 
Figure 5. A) Stereoview of the superposition of 10 refined structures of the fucose–TBA, 
conjugate 6. The average structure is shown in bold bonds. B) Top view of the fucose–TBA 
conjugate 6. C) Top view of the native TBA G-quadruplex 1 (arrows indicate the direction 
where G8 and T9 move in the fucose–TBA conjugate 6). The fucose moiety is shown in red, 
guanine core in blue, _TT_ lateral loops in cyan, and the _TGT_ loop in green. 
 
 
 
  
Figure 6. Detail on the structure of the fucose–TBA conjugate 6. Contacts of fucose with the 
bases of G8 and T9 in the TGT loop of the G-quadruplex can be observed (methyl–methyl 
interactions and a hydrogen bond shown in yellow). 
 
 
 
 
 
Figure 7. Side view of the two possible conformations of maltose–TBA conjugate 7: Left: 
maltose stacked on the G-tetrad with T9 shifted; right: maltose pointing to the bulk aqueous 
solution with T9 and G8 stacked on the G-tetrad. 
 
 
 
 
 
Figure 8. Imino region of the NMR spectra of A) 14 and B) TEL and schemes of the two 
species coexistent in solution; C) H1’-aromatic region of the NOESY spectra of 14 in D2O 
(τm=300 ms) (Experimental conditions: oligo concentration=1 µm, potassium phosphate 
buffer (10 mM), pH 7, T=5 ºC). 
 
However, the imino region of the NMR spectra of the carbohydrate– 
TEL conjugate 14 shows six sharp signals, indicating clearly the presence of 
a single conformation. The two-dimensional spectrum of 14 shown in Figure 
8 indicates that all guanines are in an anti-conformation. These data are 
consistent with the formation of a parallel symmetric quadruplex. A 
complete structural determination of this and other COCs containing 
telomeric sequences is in progress in our laboratories and will be reported in 
due time. With the present data we can already conclude that substitution 
of the 5’-terminal thymine by glucose alters the equilibrium between 
different species, promoting the formation of a stable parallel quadruplex 
(see Figure 8). 
 
Conclusion 
 
Our studies on sugar–DNA conjugates show that favorable 
carbohydrate–DNA interactions occur in a G-quadruplex structural context 
as we have observed in the case of TBA. Carbohydrates stack on top of 
guanine tetrads, and also interact with loop DNA bases through hydrogen 
bonding or hydrophobic contacts when they are available (like the 
interaction between fucose and thymine methyl groups in the fucose–TBA 
conjugate).  
 
Our results have implications in the design of new G-quadruplex 
ligands. Until now only aromatic compounds binding through pi–pi stacking 
on the guanine tetrad or through van der Waals contacts with the grooves 
of the G-quadruplex structures have been reported. Our results engage the 
possibility of developing carbohydrate-based ligands that could bind through 
CH–pi noncovalent forces together with other molecular interactions.  
 
Finally, we have also shown that by conjugating carbohydrates at the 
5’-end of G-quadruplex structures, we can alter their folding topology. The 
success of the modulation is based on manipulating the interaction between 
the terminal G-tetrads and other residues. The intrinsic versatility of 
carbohydrates introduces the possibility of modulating G-quadruplex 
systems in nanomaterials and biomedical applications. 
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Figure S1: CD spectra of carbohydrate-TBA conjugates (5-9). 
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Figure S2: Native 20% polyacrylamide gel electrophoresis of carbohydrate-TBA 
conjugates (5-9), unmodified TBA (1) and 5’-(2-hydroxyethyl)phosphate-TBA 
derivative (3). 
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Figure S3: Imino region of 1D 1H-NMR spectra of carbohydrate-TBA conjugates and 
assignment of imino proton resonances. 
 
 
 
 Figure S4. Chemical shifts differences between carbohydrate-TBA conjugates 5-9 and 
native TBA sequence 1. 
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 Figure S5: Top view of the average calculated structure of galactose-TBA conjugate 7.  
Color code: The carbohydrate moiety is shown in red, guanine tetrad in blue and the –
TGT– loop in green. 
 Figure S6: Models of maltose-TBA conjugate 7. A) Side view of the two possible 
conformations of 7 (left, maltose stacked on the G-tetrad with T9 shifted; right, maltose 
pointing to the bulk aqueous solution with T9 and G8 stacked on the G-tetrad. B) Top 
view of 7 on the conformation with maltose stacked on the G-tetrad. 
 
 
 Figure S7: Melting curves for TBA control sequences 1-3, carbohydrate-TBA 
conjugates 4-11 and TBA derivatives 12-13. 
 
 
 
 
  
 
 
 
  
 
 
 
 Figure S8: First derivative of the melting curves for TBA control sequences 1 and 3, 
carbohydrate-TBA conjugates 6, 9 and 10 and TBA derivative 12.  
 
 
 
 
  
 
 
  
Figure S9: Imino region of 1D 1H-NMR spectra of HO-CH2-CH2-OPO2- - 
AGGGTTAGGGT conjugate 15. 
 
 
 
  
 
 
 
Table S1: Melting temperatures for carbohydrate oligonucleotide conjugates 6 and 9 at 
different concentrations. 
 
Fucose-TBA 6 Cellobiose-TBA 9 
Conc. (uM) Tm (ºC) Conc. (uM) Tm (ºC) 
2.6 41.8 2.0 40.4 
3.1 41.8 4.0 41.8 
5.9 41.3 7.9 41.8 
8.0 42.9 8.1 41.7 
12.1 41.2 16.0 41.5 
59.2 41.7 61.3 42.1 
 
 
 
Table S2: Structurally relevant carbohydrate-DNA NOE contacts for the carbohydrate-
TBA conjugates 5-9. 
Conjugate 6 (Fucose-TBA) 
 
 
  
Carbohydrate-DNA NOEs 
Galactose-TBA 5 Fucose-TBA 6 Maltose-TBA 7 Lactose-TBA 8 Cellobiose-TBA 9 
G1H8-LinkH1’: m 
G1H8-LinkH2’: w 
G1H8-H5: m 
G1H8-H3: m 
G1H8-Me: w 
G1H8-H5: w 
G1H1’-Me: w 
G1H8-LinkH1’: m 
G1H8-LinkH2’: w 
G1H8-H1: w 
G1H8-H1(malt2): vw 
G1H8-H4: m 
G1H8-H3/5: w 
G1H8-H1: w 
G1H8-H3: w 
G1H8-H4/5: m 
G1H8-H6a: w 
G1H8-H6b: w 
G1H8-H1: m 
 G8’H8-Me: w 
G8’H1’-Me: w 
 G8’H8-H1: vw  
 T9H6-Me: w 
T9Me-Me:w 
   
 G15H1’-Me: vw    
 
 
Carbohydrate-Carbohydrate NOEs 
 Carb1-Carb2 Carb1-Linker G1-Linker 
GALACTOSE 
  H8-H1:m 
H8-H2:w 
FUCOSE 
 Met-H2: w H8-H1:m 
H8-H2:w 
MALTOSE 
H2-H1: m 
H1-H1: w 
  
 
Fucose-TBA 6, significant NOEs in –TGT– loop 
Experimental NOE Distance in structure of  6 Distance in native TBA 
G6 H1-G8 H4’: m 3.6 4.1 
G6 H1’-T7 H6: m 3.4 4.3 
T7 H2’-G8 H8: w 4.7 4.6 
G8 H4’-T9 Me: w 4.6 4.9 
G8 H1’-T9 Me: w 3.7 3.6 
T9 Me-G15 H1: m 4.0 5.0 
T9 H1’-G10 H1: w 5.2 5.2 
T9 Me-G10 H1: w 4.2 7.1 
T9 Me-G15 H1’: w 6.1 7.8 
T9 H1’-G15 H8: w 4.4 3.8 
 
Table S3: NMR assignments of DNA protons in control sequence (3) and 
carbohydrate-TBA conjugates (5-9) at T=5 ºC (5mM potassium phosphate, pH=7). See 
scheme for protons names. 
NH
N
N
N
O
NH2
NH
N
N N
O
H2N
HN
N N
N
O
H2N
HN
N
NN
O
NH2
R
R
R
N
N
N
N
O
N
H
H
H
R
HN
N
O
O
Me
R
OO
OH
Me
OHHO
H
H8
Linker
H1
H2
Carb
H1
H3
H4
H5
H2
H6
OO
O
H1'
H8
H2'
H2''
H3'
H4'
H5''
H5'
 
Conjugate  H1’ H2’/H2” H3’ H4’ H5’/H5” Met H6/H8 H1/H3 
G1 6.11 3.01 4.92 4.30 4.44 -- 7.43 12.15 
G2 6.06 3.07/2.37 5.19 4.44 4.30 -- 8.23 12.2 
T3 6.21 2.26/2.61 4.94 4.30 4.25 2.01 7.93 11.32 
T4 6.09 2.07/2.69 4.91 4.24 3.95 1.04 7.2 11.32 
G5 6.08 3.39/2.94 4.89 4.44 4.32/4.28 -- 7.47 12.31 
G6 5.98 2.82/2.64 5.14 4.46 4.32/4.25 -- 7.72 12.29 
T7 6.53 2.53/2.65 4.88 4.46 4.32/4.25 2.01 7.96 11.32 
G8 5.8 2.00/2.34 4.80 4.00 4.14/4.04 -- 7.49 10.71 
T9 5.85 1.99/2.44 4.65 3.81 3.58/3.04 1.83 7.29 10.33 
G10 6.09 3.76/2.95 4.94 4.29 -- -- 7.47 11.93 
G11 6.04 3.01/2.35 5.17 4.42 4.30 -- 8.26 12.11 
T12 6.21 2.25/2.61 4.93 4.30 4.25 2.01 7.93 11.32 
T13 6.14 2.11/2.76 4.93 4.32 3.95 0.99 7.27 11.32 
G14 6.11 3.53/3.00 4.95 4.45 4.30/4.21 -- 7.5 12.12 
 
 
 
 
3 
 
HO-CH2-
CH2-
OPO2-
TBA 
G15 6.19 2.72/2.46 4.82 4.27 4.20 -- 8.11 12.4 
G1 6.06 3.48/2.91 -- 4.30 -- -- 7.36 12.07 
G2 6.06 3.07/2.34 5.18 4.43 4.29 -- 8.28 12.11 
T3 6.20 2.27/2.61 4.93 4.28 4.23 1.99 7.92 11.33 
T4 6.06 2.04/2.70 4.90 4.29 3.93 1.02 7.14 11.39 
G5 6.05 3.36/2.93 4.87 4.42 4.31/4.23 -- 7.45 12.20 
G6 5.89 2.75/2.63 5.12 4.42 4.25 -- 7.61 12.12 
T7 6.55 2.54/2.66 4.87 4.48 4.34/4.24 2.00 8.00 11.27 
G8 5.85 2.10/2.36 4.79 4.01 4.15/4.09 -- 7.62 -- 
T9 5.83 1.98/2.44 4.63 3.89 3.57/2.97 1.89 7.28 10.30 
G10 6.06 3.73/2.97 -- -- -- -- 7.45 11.93 
G11 6.02 2.96/2.33 5.18 4.40 4.28/4.23 -- 8.23 12.04 
T12 6.20 2.23/2.61 4.93 4.28 4.23 1.99 7.92 11.33 
T13 6.12 2.08/2.75 4.91 4.30 3.93 0.97 7.25 11.33 
G14 6.10 3.52/2.99 4.93 4.42 4.29 -- 7.46 12.17 
 
 
 
 
5 
 
β-D-
galactose-
CH2-CH2-
OPO2
-
- 
TBA      
G15 6.18 2.70/2.44 4.79 4.29 4.18 -- 8.08 12.46 
G1 6.05 3.48/2.90 -- 4.29 -- -- 7.37 12.07 
 
G2 6.06 3.07/2.34 5.15 4.43 4.28 -- 8.29 12.11 
T3 6.20 2.27/2.61 4.93 4.28 4.23 1.99 7.92 11.33 
T4 6.06 2.03/2.70 4.90 4.29 3.93 1.01 7.14 11.39 
G5 6.05 3.36/2.93 4.88 4.41 4.30/4.23 -- 7.44 12.20 
G6 5.89 2.74/2.62 5.11 4.41 4.29 -- 7.61 12.11 
T7 6.54 2.53/2.66 4.86 4.47 4.33/4.25 1.99 8.00 11.31 
G8 5.84 2.09/2.35 4.79 4.01 4.14/4.08 -- 7.61 -- 
T9 5.83 1.97/2.44 4.64 3.90 3.56/2.98 1.89 7.29 10.32 
G10 6.07 3.71/2.97 -- -- -- -- 7.45 11.94 
G11 6.02 2.97/2.33 5.15 4.40 4.32/4.26 -- 8.22 12.05 
T12 6.19 2.24/2.60 4.93 4.28 4.23 2.00 7.92 11.33 
T13 6.12 2.09/2.75 4.91 4.29 3.93 0.97 7.25 11.33 
G14 6.10 3.52/2.99 4.93 4.44 4.28 -- 7.48 12.17 
 
 
 
 
6 
 
β-L-
fucose-
CH2-CH2-
OPO2
-
- 
TBA     
G15 6.17 2.69/2.44 4.80 4.25 4.18 -- 8.08 12.46 
G1 6.05 3.49/2.90 -- 4.28 -- -- 7.36 12.06 
G2 6.06 3.07/2.35 5.16 4.43 4.28 -- 8.27 12.10 
T3 6.20 2.24/2.60 4.93 4.29 4.23 2.00 7.93 11.33 
T4 6.06 2.04/2.70 4.90 4.29 3.92 1.02 7.14 11.39 
G5 6.04 3.36/2.92 4.87 4.43 4.31 -- 7.45 12.20 
G6 5.89 2.74/2.63 5.12 4.41 4.29 -- 7.62 12.11 
T7 6.54 2.53/2.66 4.87 4.48 4.34/4.25 2.00 8.00 11.20 
G8 5.83 2.09/2.36 4.80 4.01 4.13/4.09 -- 7.62 -- 
T9 5.83 1.98/2.44 4.64 3.89 3.56/2.99 1.89 7.29 10.31 
G10 6.09 3.73/2.98 4.94 -- -- -- 7.45 11.94 
G11 6.03 2.97/2.33 5.16 4.40 4.29 -- 8.22 12.04 
T12 6.19 2.23/2.60 4.93 4.31 -- 2.00 7.91 11.33 
T13 6.12 2.09/2.74 4.92 4.30 3.93 0.97 7.25 11.33 
G14 6.09 3.52/3.00 4.93 4.43 4.38/4.28 -- 7.47 12.18 
 
 
 
 
 
7 
 
β-D-
maltose-
CH2-CH2-
OPO2
-
- 
TBA     G15 6.18 2.70/2.44 4.80 4.25 4.19 -- 8.08 12.47 
G1 6.06 3.46/2.90 -- 4.29 -- -- 7.36 12.06 
G2 6.07 3.07/2.35 5.16 4.43 4.29 -- 8.27 12.10 
T3 6.19 2.28/2.61 4.93 4.28 4.23 1.99 7.92 11.34 
T4 6.06 2.04/2.70 4.91 4.29 3.93 1.02 7.14 11.39 
G5 6.06 3.36/2.92 4.87 4.41 4.31/4.23 -- 7.45 12.2 
G6 5.89 2.74/2.62 5.12 4.42 4.29 -- 7.61 12.12 
T7 6.55 2.53/2.66 4.86 4.48 4.34/4.25 1.99 8.00 11.22 
G8 5.84 2.10/2.36 4.79 4.01 4.15/4.09 -- 7.61 -- 
T9 5.82 1.98/2.44 4.64 3.89 3.57/2.97 1.89 7.28 10.30 
G10 6.09 3.73/2.96 -- -- -- -- 7.45 11.93 
G11 6.02 2.97/2.33 5.17 4.40 4.29/4.24 -- 8.22 12.04 
T12 6.19 2.24/2.60 4.93 4.28 4.23 1.99 7.92 11.34 
T13 6.12 2.08/2.75 4.91 4.30 3.93 0.97 7.25 11.34 
G14 6.10 3.52/2.99 4.93 4.43 4.29 -- 7.48 12.17 
 
 
 
8 
 
β-D-
lactose-
CH2-CH2-
OPO2
-
- 
TBA 
G15 6.18 2.69/2.44 4.79 4.29 4.19 -- 8.08 12.46 
G1 6.05 3.48/2.90 -- 4.29 -- -- 7.37 12.06 
G2 6.06 3.07/2.35 5.16 4.43 4.28 -- 8.27 12.10 
T3 6.20 2.28/2.61 4.92 4.28 4.22 2.00 7.91 11.33 
T4 6.06 2.04/2.70 4.90 4.29 3.93 1.03 7.14 11.39 
G5 6.06 3.36/2.92 4.87 4.42 4.32/4.23 -- 7.44 12.20 
G6 5.89 2.74/2.63 5.12 4.41 4.32 -- 7.61 12.12 
T7 6.55 2.53/2.66 4.87 4.48 4.34/4.25 2.00 8.00 11.20 
G8 5.85 2.10/2.36 4.80 4.01 4.15/4.09 -- 7.61 -- 
T9 5.83 1.98/2.44 4.64 3.89 3.56/2.97 1.90 7.28 10.30 
G10 6.09 3.73/2.96 -- -- -- -- 7.46 11.92 
G11 6.02 2.96/2.33 5.15 4.40 4.32/4.27 -- 8.22 12.04 
T12 6.20 2.24/2.60 4.92 4.28 4.23 2.00 7.91 11.33 
T13 6.12 2.09/2.75 4.90 4.29 3.93 0.97 7.25 11.33 
 
 
 
 
 
 
9 
 
β-D-
cellobiose-
CH2-CH2-
OPO2
-
-      G14 6.10 3.52/2.99 4.93 4.45 4.38/4.30 -- 7.48 12.17 
TBA G15 6.18 2.70/2.44 4.81 4.25 4.19 -- 8.08 12.46 
 
 
Table S3b: NMR assignment of DNA protons of the second species 
Conjugate Native H1’ H2’/H2” H3’ H4’ H5’/H5” Met H6/H8 
G6 5.96 2.80/2.62 5.12 4.46 -- -- 7.71 
T7 6.51 2.52/2.63 4.87 4.45 -- 1.99 7.94 
 
7 
G8 5.79 1.99/2.33 -- -- -- -- 7.48 
G6 5.97 2.81/2.62 -- -- -- -- 7.71 
T7 6.51 2.52/2.63 -- -- -- 2.00 7.95 
 
8 
G8 5.79 1.99/2.33 -- -- -- -- 7.49 
G6 5.97 2.81/2.62 -- -- -- -- 7.71 
T7 6.52 2.52/2.63 -- -- -- 2.00 7.94 
 
9 
G8 5.79 1.99/2.34 -- -- -- -- 7.49 
 
 
 
Table S3c: NMR assignment of carbohydrate protons of conjugates 5 to 9 
Conjugate H1 H2 H3 H4 H5 H6a/ 
H6b 
H6a/ H6b Me 
5 4.38 3.50 3.59 3.84 3.61 --   
6 4.35 3.43 3.55 3.64 3.68   1.18 
7 4.46/5.30 3.28/3.51 3.68/3.66 3.52/3.38 3.68/3.69 3.85/-- 3.82/3.76  
8 4.50/4.39 3.31/3.52 3.59/3.66 3.53/3.70 3.53/3.66 3.93/3.75 3.90/3.75  
9 4.47/4.44 3.29/3.26 3.53/3.47 3.49/3.58 3.49/3.45 3.89/3.74 3.87/3.69  
 
 
 
 
 Supplementary Methods 
 
Synthesis. General information. 
All chemicals were obtained from chemical suppliers and used without further 
purification, unless otherwise noted. All reactions were monitored by TLC on precoated 
Silica-Gel 60 plates F254, and detected by heating with Mostain (500 ml of 10% 
H2SO4, 25g of (NH4)6Mo7O24•4H2O, 1g Ce(SO4)2•4H2O). Products were purified by 
flash chromatography with silica gel60 (200-400 mesh).  
NMR spectra were recorded on either a Bruker AVANCE 300 or ARX 400 or Bruker 
Advance DRX 500 MHz [300 or 400 MHz (1H), 75 or 100 (13C), at room temperature 
for solutions in CDCl3, D2O or CD3OD]. Chemical shifts are referred to the solvent 
signal and are expressed in ppm. 2D NMR experiments (COSY, TOCSY, ROESY, and 
HMQC) were carried out when necessary to assign the corresponding signals of the new 
compounds. High resolution FAB (+) mass spectral analyses was obtained on a 
Micromass AutoSpec-Q spectrometer. 
 
Preparation and characterization of maltose derivatives 17-20. 
 
 
2-Benzyloxyethyl 2,3,6-tri-O-acetyl-4-O-(2,3,4,6-tetra-O-acetyl-α-D-
glucopyranosyl)-β-D-glucopyranoside (17) 
 
 
To a solution of the heptaacetyl maltose trichloroacetimidate 16[1] (4.5 g, 5.76 mmol) in 
anhydrous CH2Cl2 (50 mL) and 2-benzyloxyethanol (1.6 mL, 11.5 mmol), BF3.OEt2 (73 
µl, 0.57 mmol) was then added. After stirring at room temperature for 2 h under argon 
atmosphere, NEt3 (0.2 ml) was then added. Solvents were then removed and the crude 
was purified by silica gel column chromathography using as eluent (Hex-AcOEt, 2:1-
2:3) to give 17 (3.6 g, 81%) as a syrup. [α]D22 +40.4 (c 1 in CHCl3); δH (300 MHz, 
CDCl3): 7.028-7.00 (m, 5H, Ph), 5.11 (d, 1H, J = 3.96 Hz, H1B), 5.07 (t, 1H, J = 10.0Hz, 
H3B), 4.96 (t, 1H, J = 9.0 Hz, H3A), 4.75 (t, 1H, J= 9.6 Hz, H4B), 4.58-4.52 (m, 2H, H2A, 
H2B), 4.35 (d, 1H, J = 7.8 Hz, H1A), 4.23-4.15 (m, 2 H, CH2, H6A), 3.99-3.90 (m, 2H,  
H6B, H6’A), 3.76-3.63 (m, 4H, OCH2, H5B, , H6’B), 3.49-3.34 (m, 4H, H5A, H4A, OCH2), 
1.90-1.66 (6s, 21H. OCOCH3).  δC (75 MHz, CDCl3): 170.5, 170. 4, 170.3, 170.1, 
169.8, 169.6, 169.3 (C=O), 138.1 (Cqarom), 128.3, 127.6, 127.5 (Carom), 100.3 (C1A), 
95.5 (C1B), 75.3, 73.1, 72.7, 72.1, 72.0, 69.9, 69.2, 69.0, 68.4, 67.7, 62.8, 61.4, 20.9, 
20.8, 20.7, 20.6, 20.5. HRMS (ES+) Calcd. for C35H46O19Na (M+Na): 793.2531, found; 
793.2549.  
 
2-Benzyloxyethyl 2,3,6-tri-O-methyl-4-O-(2,3,4,6-tetra-O-methyl-α-D-
glucopyranosyl)-β-D-glucopyranoside (18) 
 
 
Compound 17 (3.0 g, 3.89 mmol) was dissolved in dry MeOH (100 mL) and Na2CO3 
(162 mg, 1.17 mmol) was then added. The reaction mixture was stirred for 2 h and IR-
120 was then added to neutralize. Solvent was then removed and the crude was used for 
next step without any further purification. To a solution of the crude (2.0 g, 4.2 mmol) 
in anhydrous DMF
 
(200 mL) at 0ºC, NaH (1.4 g, 58.8 mmol) was added. The reaction 
mixture was stirred for 10 min and MeI (5.5 mL, 88.2 mmol). After 24 h 2-propanol 
was then added dropwise and NH4Cl sat (50 mL). Organic phase was extracted with 
ethyl acetate (2x200 mL) and washed with sodium bisulfate solution (100 mL) and 
brine (100 mL). Solvents were then removed and the crude was purified by silica gel 
column chromathography using as eluent (Hex-AcOEt, 1:1-1:6) to give 18 (1.9 g, 88%) 
as a syrup. [α]D20 +38.9 (c 1 in CHCl3); δH (300 MHz, CDCl3): 7.08-7.01 (m, 5H, Ph), 
5.39 (d, 1H, J = 3.90 Hz, H1B), 4.308 (s, 2H, CH2Ph), 4.06 (d, 1H, J = 7.8 Hz, H1A),  
3.77 (m, 1H, H6A), 3.57 (t, 1H, J = 9.0 Hz, H3B), 3.51-3.24 (m, 23H, H6’A, 2xCH2, H5A 
H5B, H6B, 5xCH3O), 3.19-3.14 (m, 6H, H3A, H4B, H6’B, CH3O), 3.06 (s, 3H, CH3O), 3.00 
(t, 1H, J = 9.0 Hz, H3B), 2.93 (dd, 1H, J = 3.6, 10.0 Hz, H2B), 2.4(t, 1H, J = 8.7 Hz, 
H2A). δ13C (100 MHz, CDCl3): 138.2 (Cqarom), 128.3, 127.6, 127.5 (Carom), 103.4 
(C1A), 95.9 (C1B), 86.3, 83.7, 83.3, 81.7, 79.1, 73.6, 70.1, 71.0, 70.6, 69.2, 68.8, 60.7, 
60.4, 60.1, 59.4, 59.3, 59.2, 59.1. HRMS (ES+) Calcd. for C21H40O12Na (M+Na): 
507.2417, found; 507.2433.  
 
 
 
2-Hydroxyethyl 2,3,6-tri-O-methyl-4-O-(2,3,4,6-tetra-O-methyl-α-D-
glucopyranosyl)-β-D-glucopyranoside (19) 
 
 
 
A solution of compound 18 (500 mg, 0.87 mmol) in ethyl acetate-MeOH (1:1, 5mL) 
and Pd(OH)2 in catalytic amount was stirred under an atmosphere of hydrogen for 24 h. 
The mixture was filtered off over celite and solvents were removed. The crude was 
purified by silica gel column chromathography using as eluent (Hex-AcOEt, 1:6→0:1) 
to give 19 (386 mg, 92%) as a syrup. [α]D20 +74.0 (c 1 in CHCl3); δ1H (500 MHz, 
CDCl3): 5.39 (s, 1H, 4.06 (d, 1H, J = 7.5 Hz, H1A), 3.90 (m, 1H, H6A), 3.81 (m, 1H, 
H3B), 3.74-3.37 (m, 33H, H6’A, 2xCH2, H5A H5B, H6B, 6xCH3O, H3A, H4B, H6’B), 3.30 (s, 
3H, CH3O), 3.2 (t, 1H, J = 9.0 Hz, H3B), 3.18-3.14 (m, 1H, H2B), 3.06 (t, 1H, J = 8.0 Hz, 
H2A). δ13C (125 MHz, CDCl3): 103.9 (C1A), 96.3 (C1B), 86.3, 83.9, 83.3, 81.7, 79.2, 73.5, 
73.4, 72.0, 71.4, 70.8, 70.7, 62.4, 60.7, 60.5, 60.3, 59.7, 59.5, 59.2, 59.0. HRMS (ES+) 
Calcd. for C21H40O12Na (M+Na): 507.2417, found; 507.2433.  
 
2-[(2,3,4,6-Tetra-O-methyl-α-D-glucopyranosyl-(1→4)-2,3,6-tri-O-methyl-β-D-
glucopyranosyloxy)]ethyl (2-cyanoethyl) (N,N-diisopropyl) phosphoramidite (20) 
 
 
 
DIEA (260 µL, 1.48 mmol) and 2-cyanoethyl-N,N’-diisopropylamino-
chlorophosphoramidite (125 µL, 0.55 mmoL) were added to a solution of compound 19 
(180 mg, 0.37 mmol) in anhydrous CH2Cl2 (4 mL) at room temperature under an argon 
atmosphere. After 1.0 h no starting material was observed. Solvent was then removed 
and the crude was purified by silica gel column chromatography by using Hex/EtOAc 
(1:2 with 5% of NEt3) to give compound 20 (200 mg, 79%) as a syrup. δ1H (300 MHz, 
CDCl3): 5.41 (d, 1H, J = 3.90 Hz, H1B), 4.04 (d, 1H, J = 7.8 Hz, H1A),  3.79-3.74 (m, 
1H, H6A), 3.65-3.45 (m, 6H, H3B, H6’A, 2xCH2), 3.44-3.27 (m, 22H, OCH2, 2xCHisopropyl 
, H5A H5B, H6B, 5xCH3O), 3.21-3.10 (m, 6H, H3A, H4B, H6’B, CH3O), 3.06 (s, 3H, 
CH3O), 3.02 (t, 1H, J = 9.0 Hz, H3B), 2.96 (dd, 1H, J = 3.6, 10.0 Hz, H2B), 2.87-2.80 (m, 
1H, H2A), 2.22-2.39 (m, 2H, CH2CN), 0.98 (d, 12H, J=6.5 Hz, 4CH3isopropyl). δ13C 
(100 MHz, CDCl3): 117.9 (CN), 103.5 (C1A), 95.9 (C1B), 86.3, 83.7, 83.3, 81.7, 79.1, 
73.6, 71.0, 70.6, 69.3, 62.5, 60.8, 60.5, 60.2, 59.4, 59.3, 59.2, 59.1, 58.4, 43.0, 24.7, 
24.6, 24.5, 20.3. HRMS (ES+) Calcd. for C28H46O12Na (M+Na): 597.2887, found; 
597.2882.  
 
Proton and carbon NMR spectra of compounds 17-20. 
 
Compound 17 
 
12345678910 ppm
 
 
 
200 180 160 140 120 100 80 60 40 20 0 ppm
 
 
Compound 18 
  
10 9 8 7 6 5 4 3 2 1 ppm
 
 
 
200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm
 
 
Compound 19 
O
OMe
MeO
OMe
O
OH
O
O
OMe
MeO
MeO
MeO
 
9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
 
 
180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm
 
Compound 20 
 
 
11 10 9 8 7 6 5 4 3 2 1 0 ppm
 
 
 
190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm
 
 Synthesis of carbohydrate–oligonucleotide conjugates 
 
Carbohydrate-oligonucleotide conjugates 4-11 were synthesized on an Applied 
Biosystems 3400 synthesizer by using standard β-cyanoethylphosphoramidite 
chemistry. G-quadruplex oligonucleotide sequences 1-3, 12, 13, 14 and 15 were 
prepared by Biomers following the same methodology. Oligonucleotide conjugates 
were synthesized either on low-volume 200 nmols (LV200) or 1.0 µmol scale and using 
the DMT-off procedure. Oligonucleotide supports were treated with 33% aqueous 
ammonia for 16 h at 55ºC, then the ammonia solutions were evaporated to dryness and 
the conjugates were purified by reversed-phase HPLC in a Waters Alliance separation 
module with a PDA detector. HPLC conditions were as follows: Nucleosil 120 C18, 
250x8 mm, 10 µm column; flow rate: 3 mL/min.  
For conjugates 4-9: A 28 min linear gradient 0-30%B (mobile phase A: 5% CH3CN/ 
95% 100 mM triethylammonium acetate (TEAA; pH 6.5); mobile phase B: 100% 
CH3CN). 
For conjugates 10-11: A 28 min linear gradient 0-40%B (mobile phase A: 5% CH3CN/ 
95% 100 mM triethylammonium acetate (TEAA; pH 6.5); mobile phase B: 100% 
CH3CN). 
 
Thermal denaturation UV measurements 
 
TBA control oligonucleotides 1-3, carbohydrate-TBA conjugates 4-11 and TBA 
derivatives 12-13 were hybridized by heating the sample at 90ºC for 3 min and letting 
cool down to room temperature during 3h. Melting curves for the DNA conjugates were 
measured in a Perkin–Elmer Lambda 750 UV/Vis spectrophotometer at 295 nm while 
the temperature was raised from 10 to 80 ºC at a rate of 1.0 ºC/min. Tm values were 
calculated from the first derivative of the melting curve (using Origin software).[2] 
 
 
HPLC chromatograms of carbohydrate oligonucleotide conjugates 4-11 and 14.  
 
 
Conjugate β-D-glc-C2-TBA seq (4)   Conjugate β-D-gal-C2-TBA seq (5) 
 
     
Conjugate β-L-Fuc-C2-TBA seq (6)   Conjugate β-D-maltose-C2-TBA seq 
(7) 
     
Conjugate β-D-lactose-C2-TBA seq (8)  Conjugate β-D-cellobiose-C2-TBA 
seq (9) 
 
 
 Conjugate β-D-glc(Me)-C2-TBA seq (10)  Conjugate β-D-maltose(Me)-C2-TBA 
seq (11) 
 
 
Conjugate β-D-glc(Me)-C2- OPO2--AGGGTTAGGGT (14)  
 
 Maldi-TOF mass spectra of carbohydrate oligonucleotide conjugates 4-11 and 14. 
 
MALDI-TOF spectra were performed using a Perseptive Voyager DETMRP mass 
spectrometer, equipped with nitrogen laser at 337 nm using a 3ns pulse. The matrix 
used contained 2,4,6-trihydroxyacetophenone (THAP, 10 mg/ml in ACN/ water 1:1) 
and ammonium citrate (50 mg/ ml in water). 
 
 
Carbohydrate oligonucleotide conjugates [M-H] calc. [M-H] exp. 
β-D-glc-C2-GGTTGGTGTGGTTGG (4) 5003.1 5003.4 
β-D-gal-C2-GGTTGGTGTGGTTGG (5) 5003.1 5003.0 
β-L-Fuc-C2-GGTTGGTGTGGTTGG (6) 4987.1 4987.7 
β-D-maltose-C2-GGTTGGTGTGGTTGG (7) 5165.1 5164.8 
β-D-lactose-C2-GGTTGGTGTGGTTGG (8) 5165.1 5164.4 
β-D-cellobiose-C2-GGTTGGTGTGGTTGG (9) 5165.1 5166.6 
β-D-glc(Me)-C2-GGTTGGTGTGGTTGG (10) 5263.5 5263.1 
β-D-maltose(Me)-C2-GGTTGGTGTGGTTGG (11) 5059.3 5059.0 
β-D-glc-C2-AGGGTTAGGGT (14) 3740.0 3739.0 
 
 NMR spectroscopy and structure calculations. 
 
Samples of the conjugates were purified by HPLC, ion-exchanged with Dowex 50W 
resin and then suspended in 500 µL of either D2O or H2O/D2O 9:1 in potassium 
phosphate buffer, pH 7. Different KCl concentrations were used for NMR samples, 
ranging from 5 to 100 mM.  NMR spectra were acquired in Bruker Avance 
spectrometers operating at 600 or 800 MHz, and processed with Topspin software. 
DQF-COSY, TOCSY and NOESY (mixing times of 150 and 300ms) experiments were 
recorded in D2O at temperatures ranging from 5 ºC to 25 ºC. NOESY spectra in H2O 
were acquired with 100 ms mixing time at 5 ºC to reduce the exchange with water. The 
spectral analysis program Sparky[3] was used for semiautomatic assignment of the 
NOESY cross-peaks and quantitative evaluation of the NOE intensities. 
 
142 distance constraints with their corresponding error bounds were incorporated into 
the AMBER[4] potential energy by defining a flat-well potential term. Additional 
restraints to preserved G-tetrad planarity were included. Restrained molecular dynamics 
calculations were carried out following protocols described in our previous study. [5]  
 
Initial model structures of carbohydrate-TBA conjugates were built from unmodified 
TBA structure (PDB: 148D) by connecting the carbohydrate and glycerol and phosphate 
linker with the program Sybyl. The initial structures were refined including explicit 
solvent, periodic boundary conditions and the Particle-Mesh-Ewald method to evaluate 
long-range electrostatic interactions. Force field parameters for the carbohydrate 
moieties were taken from GLYCAM,[6] and the TIP3P model was used to describe 
water molecules.[7] Analysis of the representative structures as well as the MD 
trajectories was carried out with the program MOLMOL[8] and the analysis tools of 
AMBER. 
 
Ten final structures of conjugate 6 obtained from an explicit solvent refinement are 
displayed in Figure 5A in the main text. The calculations converge to a well-defined 
structure, with an RMSD for all heavy atoms of 0.4 Å. The final AMBER energies and 
NOE terms are reasonably low in all the structures, which do not exhibit significant 
constraint violations.  
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